Female
contraception
prevents unwanted or unintended pregnancy. When the matured egg cell leave the
ovary and ovulation begins, the chances of becoming pregnant increases. The
main advantage of using contraceptives is reduction in menstrual bleeding and
period pain.
Access
More About This Research at:
Non-hormonal
contraceptives have less side-effects in women as compared to hormonal
contraceptives. Some of the disadvantages observed in women using hormonal
contraceptives are sore breast, nausea, headache, and thrombosis.
Request
to Get the Sample Pages at:
Agile
Therapeutics Inc. is in the process of developing AG200 as an estrogen receptor
agonist for female contraception. Viramal Limited is another key player
developing therapeutics for female contraception related medical conditions.
The report
provides a comprehensive understanding of the pipeline activities covering all
drug candidates under various stages of development, with the detailed analysis
of pipeline and clinical trials.
Pipeline
analysis of drugs by phases includes product description and development
activities including information about clinical results, designations,
collaborations, licensing, grants, technology, and others.
No comments:
Post a Comment